ALLIANCE A031803

Primary Category:

Treatment Protocols

Disease Category:

Bladder, Genitourinary

Status:

Open

Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

NCT#04164082

07/19/17, no new patients may register (Step 1) to the NF2 Grade I or Grade II/III cohorts.
NCT#02523014
(Click for More Info)

Effective 09/30/20, new patient registration (Step 1) of A031803 is reopened to accrual.